77162 Federal Register / Vol. 89, No. 183 / Friday, September 20, 2024 / Notices 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–21570 Filed 9–19–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

Announcing the Intent To Award a Sole 

Source Supplement to the National 

Association of Councils on 

Developmental Disabilities (NACDD) 

AGENCY: Administration for Community 

Living, HHS. 

ACTION: Notice. 

SUMMARY: The Administration for 

Community Living (ACL) is announcing 

the award of a sole-source supplement 

for the Bridging Aging and Disability 

Networks cooperative agreement. ACL’s 

Office of Supportive and Caregiver 

Services (OSCS), Administration on 

Aging (AoA) is collaborating with the 

Projects of National Significance, the 

Administration on Disabilities (AoD) to 

provide a $180,478 supplement to the 

Bridging Aging and Disability grant. 

This grant is awarded to the NACDD, 

who is partnering with the Institute on 

Disability and Human Development at 

the University of Illinois-Chicago, the 

Lurie Institute for Disability Policy at 

Brandeis University, The Arc, and US 

Aging—the national association 

representing and supporting the 

network of Area Agencies on Aging 

(AAAs) and Title VI Native American 

Aging Programs. The goal of the grant is 

to strengthen the collaboration between 

aging and disability networks to better 

support individuals with intellectual 

and developmental disabilities (I/DD) 

and their family caregivers in future 

planning as they age. The supplemental 

funding will be used to additionally 

support aging caregivers of adults with 

I/DD and will enhance the work of the 

17 State Consortia teams to more 

directly build capacity of AAAs to serve 

adults with I/DD as they age and their 

aging caregivers. The administrative 

supplement for FY 2024 will be in the 

amount of $180,478, bringing the total 

award for FY 2024 to $600,000.00. 

FOR FURTHER INFORMATION CONTACT: For 

further information or comments 

regarding this program supplement, 

contact Larissa Crossen, U.S. 

Department of Health and Human 

Services, Administration for 

Community Living, telephone (202) 

795–7333; email Larissa.crossen@

acl.hhs.gov 

SUPPLEMENTARY INFORMATION: The 

purpose of the supplemental funding is 

to additionally support aging caregivers 

of adults with I/DD and will enhance 

the work of the 17 State Consortia 

teams. A portion of the funding 

(estimated 50%) will be used to pay for 

existing workplan activities of the 

grantee, particularly where there is 

overlap in the existing work to bridge 

the aging and disability networks to 

support aging caregivers of adults with 

I/DD. The remainder of the funding 

(estimated to be 50%) will be used to 

enhance the work of the 17 State 

Consortia teams to more directly build 

capacity of AAAs to serve adults with 

I/DD as they age and their aging 

caregivers. 

Program Name: Bridging Aging and 

Disabilities Networks. 

Recipient: NACDD. 

Period of Performance: The 

supplement award will be issued for the 

fourth year of a five-year project period, 

September 30, 2024, through September 

29, 2025. 

Award Amount: $180,478. 

Award Type: Cooperative Agreement. 

Statutory Authority: This program is 

authorized under the Developmental 

Disabilities Assistance and Bill of Rights 

Act of 2000, Title I, Subtitle E. 

CFDA Number: 93.631 Discretionary 

Projects. 

Basis for Award: NACDD is currently 

funded to carry out the objectives of this 

project, Bridging Aging and Disability 

Networks, and has completed three 

years of work. ACL believes it is in the 

best interest of the Federal Government 

to supplement the current grantee’s 

existing project. Establishing a new 

grant project at this time would be 

potentially disruptive to the current 

work already well under way. Further, 

it could create unintended duplication 

of effort and missed opportunities for 

greater coordination between the aging 

and disability networks. 

Dated: September 16, 2024. 

Alison Barkoff, 

Principal Deputy Administrator for the 

Administration for Community Living, 

performing the delegable duties of the 

Administrator and the Assistant Secretary for 

Aging. 

[FR Doc. 2024–21498 Filed 9–19–24; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2024–D–4165] 

Chemical Analysis for Biocompatibility 

Assessment of Medical Devices; Draft 

Guidance for Industry and Food and 

Drug Administration Staff; Availability 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of availability. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing the availability of the draft 

guidance entitled ‘‘Chemical Analysis 

for Biocompatibility Assessment of 

Medical Devices.’’ FDA is issuing this 

draft guidance to describe 

recommended methodological 

approaches for chemical analysis for 

biocompatibility assessment of medical 

devices. The biocompatibility of 

medical devices is evaluated based on 

the duration of exposure and nature of 

contact with the body. Chemical 

characterization is one approach that 

manufacturers can consider when 

developing a strategy for the overall 

biocompatibility assessment of a device. 

This draft guidance is not final nor is it 

for implementation at this time. 

DATES: Submit either electronic or 

written comments on the draft guidance 

by November 19, 2024 to ensure that the 

Agency considers your comment on this 

draft guidance before it begins work on 

the final version of the guidance. 

ADDRESSES: You may submit comments 

on any guidance at any time as follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 


ddrumheller on DSK120RN23PROD with NOTICES1